-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A new paper published by Oxford University in "Brain" found that the new crown infection may promote the occurrence of Guillain-Barre syndrome
Infect
Linda WG Luijten et al, Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study, Brain (2021).
Linda WG Luijten et al, Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study, Brain (2021).
Guillain - Barre syndrome is an autoimmune immune disease, the patient's immune system attacks the nerves, leading to muscle weakness, paralysis occasionally occur
Among patients with Guillain-Barré syndrome in the 4 months since the pandemic, 22% of patients had previously been infected with the new coronavirus.
Among patients with Guillain-Barré syndrome in the 4 months since the pandemic, 22% of patients had previously been infected with the new coronavirus.
Original link:
Linda WG Luijten et al, Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study, Brain (2021).
Linda WG Luijten et al, Guillain- Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study, Brain (2021) DOI:.
10.
1093 / brain / awab279
in this message